Universe Pharmaceuticals (NYSE:UPC) Trading Down 0.4% – Should You Sell?

Universe Pharmaceuticals INC (NYSE:UPC) traded down 0.4% on Friday . The company traded as low as $0.62 and last traded at $0.64. 594,071 shares were traded during mid-day trading, a decline of 7% from the average session volume of 635,835 shares. The stock had previously closed at $0.64.

Universe Pharmaceuticals Price Performance

The company has a quick ratio of 1.46, a current ratio of 1.63 and a debt-to-equity ratio of 0.08. The stock has a fifty day moving average of $1.86 and a two-hundred day moving average of $23.14.

Institutional Trading of Universe Pharmaceuticals

A hedge fund recently bought a new stake in Universe Pharmaceuticals stock. MML Investors Services LLC acquired a new position in Universe Pharmaceuticals INC (NYSE:UPC) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 234,260 shares of the company’s stock, valued at approximately $57,000. MML Investors Services LLC owned approximately 6.46% of Universe Pharmaceuticals at the end of the most recent quarter. Institutional investors and hedge funds own 0.18% of the company’s stock.

About Universe Pharmaceuticals

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.